Bustos L, Sattler R
Front Mol Med. 2024; 3:1075805.
PMID: 39165755
PMC: 11334001.
DOI: 10.3389/fmmed.2023.1075805.
Ferrer I
J Alzheimers Dis. 2024; 100(s1):S153-S164.
PMID: 39031364
PMC: 11380266.
DOI: 10.3233/JAD-240389.
de Sousa L, Paschoal D, Novato W
J Mol Model. 2024; 30(7):200.
PMID: 38850372
DOI: 10.1007/s00894-024-05991-4.
Lao P, Edwards N, Flores-Aguilar L, Alshikho M, Rizvi B, Tudorascu D
Sci Rep. 2024; 14(1):12334.
PMID: 38811657
PMC: 11137035.
DOI: 10.1038/s41598-024-61962-y.
Thai Q, Tran P, Phung H, Pham M, Ngo S
RSC Adv. 2024; 14(21):15112-15119.
PMID: 38720971
PMC: 11078207.
DOI: 10.1039/d4ra02197e.
Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History.
Bermejo-Pareja F, Del Ser T
J Clin Med. 2024; 13(2).
PMID: 38256670
PMC: 10816332.
DOI: 10.3390/jcm13020536.
Clarity on the blazing trail: clearing the way for amyloid-removing therapies for Alzheimer's disease.
Lian Y, Jia Y, Wong J, Zhou X, Song W, Guo J
Mol Psychiatry. 2023; 29(2):297-305.
PMID: 38001337
DOI: 10.1038/s41380-023-02324-4.
Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update.
Huang L, Kuan Y, Lin H, Hu C
J Biomed Sci. 2023; 30(1):83.
PMID: 37784171
PMC: 10544555.
DOI: 10.1186/s12929-023-00976-6.
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.
Ferrer I
Free Neuropathol. 2023; 3.
PMID: 37284149
PMC: 10209894.
DOI: 10.17879/freeneuropathology-2022-3806.
Amyloid inhibition by molecular chaperones can be translated to Alzheimer's pathology .
Abelein A, Johansson J
RSC Med Chem. 2023; 14(5):848-857.
PMID: 37252101
PMC: 10211315.
DOI: 10.1039/d3md00040k.
The Prion Basis of Progressive Neurodegenerative Disorders.
Joshi T, Ahuja N
Interdiscip Perspect Infect Dis. 2023; 2023:6687264.
PMID: 36825209
PMC: 9943612.
DOI: 10.1155/2023/6687264.
Effects of multi-mode physical stimulation on APP/PS1 Alzheimer's disease model mice.
Liu S, Li S, Xia Y, Zhang H, Tian J, Shan C
Heliyon. 2023; 8(12):e12366.
PMID: 36590474
PMC: 9800530.
DOI: 10.1016/j.heliyon.2022.e12366.
Amyloid Beta in Aging and Alzheimer's Disease.
Sehar U, Rawat P, Reddy A, Kopel J, Reddy P
Int J Mol Sci. 2022; 23(21).
PMID: 36361714
PMC: 9655207.
DOI: 10.3390/ijms232112924.
How the immune system shapes neurodegenerative diseases.
Mason H, McGavern D
Trends Neurosci. 2022; 45(10):733-748.
PMID: 36075783
PMC: 9746609.
DOI: 10.1016/j.tins.2022.08.001.
Therapeutic roles of plants for 15 hypothesised causal bases of Alzheimer's disease.
Tyler S, Tyler L
Nat Prod Bioprospect. 2022; 12(1):34.
PMID: 35996065
PMC: 9395556.
DOI: 10.1007/s13659-022-00354-z.
Adenosine receptor signalling in Alzheimer's disease.
Trinh P, Baltos J, Hellyer S, May L, Gregory K
Purinergic Signal. 2022; 18(3):359-381.
PMID: 35870032
PMC: 9391555.
DOI: 10.1007/s11302-022-09883-1.
Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites.
Vrijsen S, Vrancx C, Del Vecchio M, Swinnen J, Agostinis P, Winderickx J
Front Neurosci. 2022; 16:900338.
PMID: 35801175
PMC: 9253489.
DOI: 10.3389/fnins.2022.900338.
Atomistic investigation of an Iowa Amyloid-β trimer in aqueous solution.
Ngo S, Phung H, Vu K, Vu V
RSC Adv. 2022; 8(73):41705-41712.
PMID: 35558787
PMC: 9091969.
DOI: 10.1039/c8ra07615d.
The Emerging Roles of the β-Secretase BACE1 and the Long Non-coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegenerative Diseases and Cancer.
Sayad A, Najafi S, Hussen B, Abdullah S, Movahedpour A, Taheri M
Front Aging Neurosci. 2022; 14:853180.
PMID: 35386116
PMC: 8978056.
DOI: 10.3389/fnagi.2022.853180.
Proteasome activity modulates amyloid toxicity.
Galvin J, Curran E, Arteaga F, Goossens A, Aubuchon-Endsley N, McMurray M
FEMS Yeast Res. 2022; 22(1).
PMID: 35150241
PMC: 8906389.
DOI: 10.1093/femsyr/foac004.
